article thumbnail

Four ways Biogen is tackling digital innovation in neurological disease

pharmaphorum

It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. Hadjiat says the team can build digital tools for clinicians because they have a team that represents both technical and clinical expertise. About the interviewee.

article thumbnail

What will the 2023 drug discovery landscape look like?

Drug Discovery World

The researchers noted that such virtual trials incorporate numerous evidence-based assumptions regarding disease pathogenesis, therapeutic mechanism, side effects and a host of other factors which could impact the outcome. Quantifying the use of connected digital products in clinical research. The Lancet Oncology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Utility of Liquid Biopsy in Oncology Clinical Trials

XTalks

“Liquid biopsies have demonstrated promising activity in multiple clinical settings, but the great enthusiasm and expectations around them can be harmful if not adequately managed,” said Dr. El Mustapha Bahassi, PhD, Director, Clinical Laboratory Sciences, at the global clinical research organization (CRO) Medpace.

article thumbnail

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

Clinical research experts from the CRO Medpace shared insights about the operational and regulatory considerations for neuroscience trials with direct CNS administration. The Neurology and Radiology departments are vital for consultation and imaging, which is needed to establish baselines for a study.

Trials 83
article thumbnail

BioSpace Movers & Shakers, Nov. 20

The Pharma Data

Previously, Baffa was Therapeutic Area Head of Oncology, Global Clinical Development for Shire. Hojvat served as the director of the Division of Microbiology Devices at the Center for Devices and Radiological Health at the Food and Drug Administration for 12 years. HotSpot Therapeutics – Eva Jack was named COO of Boston-based HotSpot.

article thumbnail

The rise of real-world evidence: unlocking the potential in EHRs

pharmaphorum

International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health records (EHRs) using artificial intelligence (AI) and clinical Natural Language Processing (NLP) techniques. AI use in the pandemic.

Doctors 115
article thumbnail

COVID-19 Pandemic Coverage

XTalks

Below are some free webinars you can register for that have delved into the topic: Continuing Clinical Research Innovations After COVID-19. The Impact of COVID-19 on Early Clinical Development – What the New Landscape Will Look Like. Addressing the Rapidly Evolving Vaccine Development Landscape. Drugs and Vaccines.